Michael Macdonnell

Michael Macdonnell is a Non-Executive Director at the Royal National Orthopaedic Hospital (RNOH) NHS Trust, appointed to this position effective April 1, 2024.12 In his role at RNOH, he serves as the Chair of the Finance and Compliance Committee and is a member of the Trust Board and Remuneration Committee.1

Professional Background

Macdonnell's current primary role is as the global head of healthcare and pharma partnerships at Huma Therapeutics, a UK-based technology company focused on digital-first care and research.1 His career has been marked by significant positions in healthcare and technology:

• Previously worked as the director of partnerships and deployment for DeepMind, a leading AI lab, and subsequently for Google Health, operating both in the UK and internationally.1
• Served as the director of strategy for NHS England and later as the national director of system transformation.13

Experience in Healthcare Systems

Macdonnell has extensive experience in healthcare system integration and transformation:

• At NHS England, he was responsible for integrating health systems across the English NHS, focusing on joining up primary care and hospitals, as well as mental and physical health care.3
• He played a key role in driving the implementation of the NHS Five Year Forward View as the Director of the Strategy Group at NHS England.5

Academic and Advisory Roles

Beyond his executive positions, Macdonnell has been involved in academic and advisory capacities:

• Associated with Imperial College London, where he contributed to healthcare strategy and transformation initiatives.5
• Engaged with the Centre for Science and Policy at the University of Cambridge, providing expertise in health system transformation.4

Michael Macdonnell's appointment to the RNOH Trust Board brings a wealth of experience in healthcare strategy, digital health, and system integration, which aligns with the trust's vision for innovative and efficient healthcare delivery.